You have access
The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma
GOUJI TOYOKAWA, KENICHI TAGUCHI, MAKOTO EDAGAWA, SHINICHIRO SHIMAMATSU, RYO TOYOZAWA, KANAME NOSAKI, FUMIHIKO HIRAI, MASAFUMI YAMAGUCHI, MOTOTSUGU SHIMOKAWA, TAKASHI SETO, MITSUHIRO TAKENOYAMA, RYUJI HAMAMOTO, KENJI SUGIO and YUKITO ICHINOSE
Anticancer Research September 2016, 36 (9) 4841-4846;